99mTc-甲氧基异丁基异腈甲状旁腺显像对无症状原发性甲状旁腺功能亢进症患者未来手术资格的预测价值
本回顾性研究纳入94例接受99mTc-甲氧基异丁基异腈(99mTc-sestamibi)SPECT/CT显像的无症状甲状旁腺功能亢进症患者,其中35例在显像时不符合手术标准并完成至少1年随访。中位随访2.4年(范围1-4年)显示,阳性显像组12例中6例变为符合手术标准,阴性显像组23例中20例仍不符合手术标准。阳性甲状旁腺SPECT/CT预测无症状甲状旁腺功能亢进症患者随时间推移更可能符合手术标准。
要点
- 35例显像时不符合手术标准的无症状甲状旁腺功能亢进症患者中,阳性显像组12例有6例变为符合手术标准。
- 阴性显像组23例中20例在随访结束时仍不符合手术标准。
- 中位随访2.4年(范围1-4年),阳性甲状旁腺SPECT/CT预测未来更可能符合手术标准。
核心结论
- 阳性甲状旁腺SPECT/CT预测无症状甲状旁腺功能亢进症患者在就诊时不符合手术标准的情况下,随时间推移更可能符合手术标准。
研究设计与样本
- 回顾性研究,复习94例无症状甲状旁腺功能亢进症患者的记录,这些患者接受了99mTc-甲氧基异丁基异腈(99mTc-sestamibi)SPECT/CT显像。
- 其中35例在显像时不符合手术标准,包括12例阳性显像和23例阴性显像,对这些患者评估了至少1年的随访记录。
- 比较显像发现与随访结束时的手术资格。
主要发现
- 中位随访2.4年(范围1-4年)。
- 在最初不符合手术标准的35例患者中,阳性显像组12例中有6例变为符合手术标准。
- 阴性显像组23例中有20例在随访结束时仍不符合手术标准。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Patients with asymptomatic primary hyperparathyroidism might have a positive Tc-sestamibi parathyroid but do not meet criteria for surgical resection when the disease is diagnosed. However, many of these asymptomatic patients will become symptomatic or meet criteria for surgery later on. The aim of this study was to determine whether a positive sestamibi scan can precede future surgical eligibility in these patients. METHODS: This retrospective study reviewed the records of 94 asymptomatic patients who had hyperparathyroidism and underwent Tc-sestamibi study with SPECT/CT imaging. Among them, 35 patients, including 12 with positive and 23 with negative sestamibi parathyroid scan, did not meet the criteria for surgery at the time of imaging, and follow-up record for at least 1 year was assessed on these patients. The imaging findings and the eligibility for surgery at the end of the follow-up were compared. RESULTS: With a median follow-up of 2.4 years (range, 1-4 years), among all 35 patients who were initially not eligible for surgery, 6 of 12 patients with a positive sestamibi scan became eligible for surgery, whereas 20 of 23 patients with negative scans remained ineligible for surgery. CONCLUSIONS: Positive parathyroid SPECT/CT predicted a higher possibility of meeting surgical criteria over time in asymptomatic hyperparathyroidism patients who are not surgery eligible at the time of presentation.
引用
- Cheng Z, Zou S, Peng D, et al. Prognostic Value of 99mTc-Sestamibi Parathyroid Scintigraphy in Predicting Future Surgical Eligibility in Patients With Asymptomatic Primary Hyperparathyroidism. Clin Nucl Med. 2018. PMID: 29261636. doi:10.1097/RLU.0000000000001941
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。